Matthew A. Powell, MD

Washington University School of Medicine

PowellDr. Powell is an Assistant Professor in the Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Washington University School of Medicine. He maintains a busy clinical practice caring for patients with known or suspected gynecologic malignancies or precancers, or other complicated medical / gynecologic problems. He has special expertise in minimally invasive cancer surgery, (laparoscopy and the da Vinci™ Surgical System) as well as fertility sparing surgery. Dr. Powell is involved in both clinical and molecular research in the field of gynecologic cancers (ovarian, uterine, cervical, vulvar, peritoneum, placenta and fallopian tube). He currently serves on the National Institutes of Health sponsored Gynecologic Oncology Group as a study chairman and committee member of the Uterine Corpus Committee. He currently oversees a national uterine sarcoma study involving chemotherapy. Locally he serves on the Washington University’s Human Studies Committee and Protocol review committee for the Siteman Cancer Center.

Dr. Powell has written several book chapters and published numerous peer reviewed journal articles on the subject of gynecologic oncology. In addition, he has editorial responsibilities with multiple journals including Gynecologic Oncology and Clinical Cancer Research. His areas of interest include gynecologic oncology, endometrial cancer, vulva carcinoma, ovarian cancer, cervical cancer, adnexal masses, tumors, and lymphadenectomy.

Dr. Powell was a research fellow at the University of Washington in 1989. In 1990, he received his BS in Biochemistry and Biophysics from Washington State University. He earned his MD in 1995 from Michigan State University. Dr. Powell’s completed his residency in Obstetrics and Gynecology at Ohio State University Hospital and Clinics in 1999. He completed a fellowship in Gynecologic Oncology at Washington University School of Medicine in 2002.

Spotlight

Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.

Awareness

Vaccine efficacy against vulvar infection with HPV 16/18 was comparable to the efficacy found against cervical infection 4 years after vaccination, according to researchers with the National Cancer Institute.

Research

The Foundation has published its 2014-2015 Research Grants and Awards Booklet with Applications. Please consider applying to become part of an elite group of physician-scientists committed to the well-being of women at risk for/affected by gyn malignancies.

Education

The next Ovarian Cancer Survivors Course will be Saturday, July 26, 2014 in Boston. For more information on courses, click here.